Diazenyl Derivatives and their Complexes as Anticancer Agents.

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Organic Synthesis

Background:

• Numerous diazenyl compounds, including diazenecarboxamides, diazeniumdiolates, and diazenyl complexes, have been synthesized and evaluated for anticancer properties.
• Many of these derivatives exhibit significant cytotoxic activity against a range of cancer cell lines, including those resistant to conventional chemotherapy.

Purpose of the Study:

• To review and update information on the synthetic methods and cytotoxic potential of diazenyl derivatives.
• To highlight recent developments in the field of diazenyl compounds for anticancer drug discovery.

Main Methods:

• Literature review of synthetic methodologies for diazenyl derivatives.
• Analysis of reported cytotoxic activities against various cancer cell lines.
• Examination of mechanisms of action, including alkylation, nitric oxide (NO) release, and enzyme/receptor targeting.

Main Results:

• Diazenyl derivatives demonstrate diverse mechanisms of action, such as alkylating agents, NO releasers, and inhibitors of key enzymes (e.g., GST, AGT, CDKs) and receptors (e.g., tyrosine kinase, EGFR).
• These compounds induce DNA damage, necrosis, and apoptosis, leading to cancer cell death.
• Promising activity has been observed, even in drug-resistant cancer models.

Conclusions:

• Diazenyl derivatives represent a valuable class of compounds with significant potential for anticancer drug development.
• Further molecular modifications of these derivatives could lead to novel anticancer agents with improved efficacy and broader applicability.